TNFRSF10B and non-small cell lung carcinoma: Additionally, CD133+ CSCs of both H460 and H2170 cell lines of non-small cell lung cancer highly express death receptor 5 (DR5) and undergo apoptosis when treated with TRAIL-expressing mesenchymal stem cells (MSCs) [5].